INBX
Price
$82.60
Change
-$2.48 (-2.91%)
Updated
Feb 4, 02:51 PM (EDT)
Capitalization
1.24B
47 days until earnings call
Intraday BUY SELL Signals
SNTI
Price
$0.88
Change
-$0.10 (-10.20%)
Updated
Feb 4, 03:19 PM (EDT)
Capitalization
26.02M
Intraday BUY SELL Signals
Interact to see
Advertisement

INBX vs SNTI

Header iconINBX vs SNTI Comparison
Open Charts INBX vs SNTIBanner chart's image
Inhibrx Biosciences
Price$82.60
Change-$2.48 (-2.91%)
Volume$100
Capitalization1.24B
Senti Biosciences
Price$0.88
Change-$0.10 (-10.20%)
Volume$801
Capitalization26.02M
INBX vs SNTI Comparison Chart in %
INBX
Daily Signal:
Gain/Loss:
SNTI
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
INBX vs. SNTI commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a StrongBuy and SNTI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (INBX: $85.08 vs. SNTI: $0.98)
Brand notoriety: INBX and SNTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INBX: 87% vs. SNTI: 12%
Market capitalization -- INBX: $1.24B vs. SNTI: $26.02M
INBX [@Biotechnology] is valued at $1.24B. SNTI’s [@Biotechnology] market capitalization is $26.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 1 FA rating(s) are green whileSNTI’s FA Score has 1 green FA rating(s).

  • INBX’s FA Score: 1 green, 4 red.
  • SNTI’s FA Score: 1 green, 4 red.
According to our system of comparison, INBX is a better buy in the long-term than SNTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 4 TA indicator(s) are bullish while SNTI’s TA Score has 4 bullish TA indicator(s).

  • INBX’s TA Score: 4 bullish, 5 bearish.
  • SNTI’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SNTI is a better buy in the short-term than INBX.

Price Growth

INBX (@Biotechnology) experienced а +15.77% price change this week, while SNTI (@Biotechnology) price change was -7.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

INBX is expected to report earnings on Mar 23, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($1.24B) has a higher market cap than SNTI($26M). SNTI has higher P/E ratio than INBX: SNTI (4.27) vs INBX (0.20). INBX YTD gains are higher at: 7.696 vs. SNTI (-5.769). SNTI has higher annual earnings (EBITDA): -60.3M vs. INBX (-143.46M). INBX has more cash in the bank: 153M vs. SNTI (12.2M). SNTI has less debt than INBX: SNTI (30.1M) vs INBX (107M). INBX has higher revenues than SNTI: INBX (1.4M) vs SNTI (0).
INBXSNTIINBX / SNTI
Capitalization1.24B26M4,758%
EBITDA-143.46M-60.3M238%
Gain YTD7.696-5.769-133%
P/E Ratio0.204.275%
Revenue1.4M0-
Total Cash153M12.2M1,254%
Total Debt107M30.1M355%
TECHNICAL ANALYSIS
Technical Analysis
INBXSNTI
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 14 days ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
81%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
INBX
Daily Signal:
Gain/Loss:
SNTI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IMLPX10.650.20
+1.91%
MainGate MLP I
PRASX22.510.13
+0.58%
T. Rowe Price New Asia
SRUAX15.96N/A
N/A
Meeder Spectrum Adviser
WESWX10.40-0.02
-0.19%
TETON Westwood Equity AAA
TEGRX28.46-0.13
-0.45%
Templeton Growth R

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+3.47%
AXON - INBX
48%
Loosely correlated
-1.89%
AKESF - INBX
45%
Loosely correlated
N/A
SNTI - INBX
39%
Loosely correlated
-2.97%
ACET - INBX
39%
Loosely correlated
-3.51%
GNTA - INBX
38%
Loosely correlated
-10.28%
More

SNTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNTI has been loosely correlated with PPBT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if SNTI jumps, then PPBT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNTI
1D Price
Change %
SNTI100%
-2.97%
PPBT - SNTI
60%
Loosely correlated
-2.79%
TCRT - SNTI
47%
Loosely correlated
-6.16%
INBX - SNTI
41%
Loosely correlated
+3.47%
RXRX - SNTI
33%
Loosely correlated
-1.91%
PTCT - SNTI
32%
Poorly correlated
-0.07%
More